Search results
Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
Reuters via AOL· 5 hours agoThe therapy is currently in late-stage development for the treatment of pulmonary arterial...
Chiesi buys into Gossamer’s Winrevair rival, betting almost $500M
FierceBiotech· 2 hours agoItalian pharma Chiesi is betting almost $500 million on Gossamer Bio's pulmonary arterial...
Gossamer Bio reports positive phase 2 trial results for PAH treatment By Investing.com
Investing.com· 3 days agoGossamer Bio, Inc. (NASDAQ:GOSS), a clinical-stage biopharmaceutical company, has announced the...
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoUnited Therapeutics Corp showcases robust revenue growth and solid operational performance....
Merck Supports PAH Patients With Unbranded Campaign -- And New Drug
MediaPost· 7 days agoPatients can “Outnumber PAH” by developing a strong support team, advises an unbranded educational campaign launched by Merck against pulmonary arterial hypertension (< ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoRating of 87. But the biotech stock undercut its 50-day line on April 10. Gyre is also a new...
Bill banning certain driveway, pavement sealants to take effect this July
Virginia Mercury via Yahoo News· 4 days agoAfter attempting to ban the products in previous sessions, the Democratic legislature passed a bill...
United Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoUnited Therapeutics Corporation (NASDAQ:UTHR) Q1 2024 Earnings Call Transcript May 1, 2024 United...
United Therapeutics Surpasses Analyst Revenue Forecasts with Str
Guru Focus· 5 days agoThis performance not only demonstrates robust growth but also significantly exceeds the analyst estimates of $623.97 million for the quarter. United Therapeutics, headquartered in Silver Spring ...
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
Zacks via Yahoo Finance· 3 days agoAgios (AGIO) reports mixed earnings results for first-quarter 2024. Though sales miss the mark,...